Sign in

CIK 0000874015

  • Large accelerated filer

IONIS PHARMACEUTICALS INC

Sign in to watch
Ticker
IONS
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
CA
Entity type
Operating
EIN
330336973
Phone
+1 760-931-9200
Business address
2855 GAZELLE COURT, CARLSBAD, CA, 92010
Former names
ISIS PHARMACEUTICALS INC
Open-market buys, last 90 days
$148,200
in 1 filing
Open-market sales, last 90 days
$61,389
in 2 filings

Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2025-01-15 Baroldi Joseph EVP, Chief Business Officer Exercise or conversion +8,787 28,418
2025-01-15 Baroldi Joseph EVP, Chief Business Officer Exercise or conversion +2,460 4,100
2025-01-15 Baroldi Joseph EVP, Chief Business Officer Grant or award · Performance Restricted Stock Units +22,000 51,290
2025-01-15 Baroldi Joseph EVP, Chief Business Officer Grant or award · Restricted Stock Unit +33,000 86,135
2025-01-15 Baroldi Joseph EVP, Chief Business Officer Exercise or conversion · Restricted Stock Unit −8,787 77,348
2025-01-15 Baroldi Joseph EVP, Chief Business Officer Grant or award · Restricted Stock Unit +3,750 10,784
2025-01-15 Baroldi Joseph EVP, Chief Business Officer Exercise or conversion · Restricted Stock Unit −2,460 8,324
2025-01-02 Geary Richard S EVP, Chief Development Officer Grant or award · Non-Qualified Stock Option (right to buy) +22,000 22,000
2025-01-02 Swayze Eric EVP Research Grant or award · Non-Qualified Stock Option (right to buy) +22,000 22,000
2025-01-02 Swayze Eric EVP Research Grant or award · Non-Qualified Stock Option (right to buy) +163 163
2025-01-02 Schneider Eugene EVP, Chf Clinical Develop Ofcr Grant or award · Non-Qualified Stock Option (right to buy) +22,000 22,000
2025-01-02 O'NEIL PATRICK R. EVP CLO & General Counsel Grant or award · Non-Qualified Stock Option (right to buy) +22,000 22,000
2025-01-02 Monia Brett P Chief Executive Officer Grant or award · Non-Qualified Stock Option (right to buy) +86,263 86,263
2025-01-02 Jenne Kyle EVP, Chf GL Pdt Str Ofcr Grant or award · Non-Qualified Stock Option (right to buy) +18,700 18,700
2025-01-02 HOUGEN ELIZABETH L EVP, Finance & CFO Grant or award · Non-Qualified Stock Option (right to buy) +31,000 31,000
2025-01-02 Devers Shannon L. EVP, Chief Human Resources Ofc Grant or award · Non-Qualified Stock Option (right to buy) +22,000 22,000
2025-01-02 Birchler Brian EVP, Corp and Development Ops Grant or award · Non-Qualified Stock Option (right to buy) +22,000 22,000
2025-01-02 BENNETT C FRANK EVP, Chief Scientific Officer Grant or award · Non-Qualified Stock Option (right to buy) +22,000 22,000
2025-01-02 Baroldi Joseph EVP, Chief Business Officer Grant or award · Non-Qualified Stock Option (right to buy) +22,000 22,000
2025-01-02 Baroldi Joseph EVP, Chief Business Officer Grant or award · Non-Qualified Stock Option (right to buy) +2,500 2,500

Page 35 of 44 · 873 trades